Skip to content

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
15%+3.8pp
Merck & Co. logo
Merck & Co.MRK
13.6%-13.7pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
AbbVie logo
AbbVieABBV
5.8%-1.5pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-3,921.1%-4,562pp
Incyte logo
IncyteINCY
26.7%+26.2pp

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Operating margin-168.6%-52.7pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Calculated from Arcus Biosciences’s reported figures.

Based on trailing twelve months.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's net margin?
Arcus Biosciences (RCUS) reported net margin of -156.4% in Q1 2026.
How has Arcus Biosciences's net margin changed year-over-year?
Arcus Biosciences's net margin increased by 43.6% year-over-year, from -277.3% to -156.4%.
What is the long-term trend for Arcus Biosciences's net margin?
Over 5 years (2020 to 2025), Arcus Biosciences's net margin has grown at a -1.9% compound annual growth rate (CAGR), from -157.5% to -142.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.